Objective: To compare the effectiveness and costeffectiveness of erlotinib versus gefitinib as first-line treatment of epidermal growth factor receptor– activating mutation-positive non–small-cell lung cancer patients. Design: Indirect treatment comparison and a costeffectiveness assessment.

There is a general agreement among software engineering practitioners that software inspections are an important technique to achieve high software quality at a reasonable cost. However, there are many ways to perform such inspections and many factors that affect their costeffectiveness. It is therefore important to be able to estimate this cost-effectiveness in order to monitor it, improve it,...

Introduction Economic evaluation alongside trials is often based on data collected through self-reported questionnaires. Consequently, there are consistent problems with incomplete (missing) data irrespective of how well data collection methods are designed. Missing data poses a significant problem when conducting economic analyses of clinical trials, potentially leading to incorrect conclusion...